1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020

Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches.The key market players profiled in this report are BD Biosciences, Beckman Coulter, Merck Millipore, Amnis Corporation, Life Technologies Corporation, Luminex Corporation, Morphosys AG, eBiosciences Inc., Partec Gmbh and Advanced Analytical Technologies, Inc.

KEY BENEFITS
The report ranks the factors that are responsible to accelerate the market growth of flow cytometryMarket is forecasted for period of seven years from 2013 to 2020, with market revenues for 2 historic years  - 2011 and 2012Identification and analysis of key investment pockets for flow cytometry market playersIdentification of challenges that must be addressed and overcome in the flow cytometry market to achieve fiscal success throughout the marketThe report identifies and profiles key market participants that would drive innovation in the flow cytometry market  

KEY MARKET SEGMENTS
GLOBAL MARKET, BY PRODUCTFC instrumentsReagentsConsumablesSoftwareServicesAccessoriesGLOBAL MARKET, BY TECHNOLOGYCell based TechnologiesBead-based TechnologiesGLOBAL MARKET, BY APPLICATIONClinicalApoptosisCell Cycle AnalysisCell sortingCell ViabilityResearch FieldsOrgan transplantationCancerImmunodeficiency DiseaseHematology Haematological MalignanciesGLOBAL MARKET, BY END USERSCommercial OrganizationsHospitalsAcademic InstitutesMedical SchoolsClinical Testing LabsOthersGLOBAL MARKET,

BY GEOGRAPHY
North AmericaEuropeAsia PacificRoW

KEY AUDIENCES
Clinical institutesResearch institutesPharma and biotech companiesAcademic institutes

Table Of Contents

Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020
CHAPTER 1 INTRODUCTIONandnbsp;1.1 Objective and Scope of the Reportandnbsp;1.2 Key Deliverables of the Reportandnbsp;1.3 Unique Benefits of the Reportandnbsp;1.4 Key Audiencesandnbsp;1.5 Research Methodologyandnbsp; andnbsp; 1.5.1 Secondary researchandnbsp; andnbsp; 1.5.2 Primary researchandnbsp; andnbsp; 1.5.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 GLOBAL FLOW CYTOMETRY MARKET OVERVIEWandnbsp;3.1 Market Definition and Scopeandnbsp; andnbsp; 3.1.1 Key applications of Flow cytometryandnbsp; andnbsp; 3.1.2 Application of Flow Cytometry in Gender Selectionandnbsp; andnbsp; 3.1.3 Flow cytometry in Omics Technologyandnbsp; andnbsp; andnbsp; andnbsp;3.1.3.1 Applications of omics technologyandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.3.1.1 Lung disease identificationandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.3.1.2 Quantifying Abnormalitiesandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.3.1.3 Genetic Trait Diagnosisandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.3.1.4 Pharmacogenomicsandnbsp; andnbsp; 3.1.4 Flow Cytometry in Immunophenotypingandnbsp; andnbsp; andnbsp; andnbsp;3.1.4.1 Immunophenotyping in hematology applicationsandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.4.1.1 Erythrocyte analysisandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.4.1.2 Leukocyte Analysisandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 3.1.4.1.3 Platelet analysisandnbsp; andnbsp; 3.1.5 Flow cytometry in blood bankandnbsp; andnbsp; 3.1.6 Optimization of Flow Cytometry by Information Technologyandnbsp; andnbsp; 3.1.7 Use Of Flow Cytometry In Resource-Poor Regionsandnbsp;3.2 Top factors impacting Flow cytometry Marketandnbsp;3.3 Top three winning strategies in the flow cytometry marketandnbsp; andnbsp; 3.3.1 Product Launchandnbsp; andnbsp; 3.3.2 Agreement and Collaborationandnbsp; andnbsp; 3.3.3 Acquisitionandnbsp;3.4 Top investment pockets in flow cytometry marketandnbsp; andnbsp; 3.4.1 Flow cytometry market- by clinical applicationandnbsp; andnbsp; 3.4.2 Flow cytometry market- by Research applicationandnbsp; andnbsp; 3.4.3 Flow cytometry market- by End usersandnbsp;3.5 Porterandrsquo;s Five Forces Analysisandnbsp; andnbsp; 3.5.1 Intense Competition DecliningSupplierandrsquo;s Powerandnbsp; andnbsp; 3.5.2 Wide Range of Product Availability Enhances Buyerandrsquo;s Powerandnbsp; andnbsp; 3.5.3 Strategies to Be in Place to Combat Competitionandnbsp; andnbsp; 3.5.4 High Investment Restricting Low Investment New Comersandnbsp; andnbsp; 3.5.5 Pricing Issues Impacting Adoption Ratesandnbsp;3.6 Reimbursement Scenarioandnbsp;3.7 Regulatory Issuesandnbsp; andnbsp; 3.7.1 Challenges- in FDA Clearanceandnbsp; andnbsp; 3.7.2 Impact of ASR Ruleandnbsp; andnbsp; 3.7.3 Validation Challenges- Cell-Basedandnbsp; andnbsp; 3.7.4 Validation Requirements (CLIA, CAP)andnbsp; andnbsp; 3.7.5 LDT Guidelines on Cell-based Fluorescenceandnbsp; andnbsp; 3.7.6 Change in Regulationsandnbsp;3.8 Case studiesandnbsp; andnbsp; 3.8.1 Case study 1: Expansion of the number of antibody conjugatesandnbsp; andnbsp; 3.8.2 Case study 2: Recognition of target antibodies conjugates, Anti-human CD3: FITC.andnbsp; andnbsp; 3.8.3 Case study 3:To prove precursor B acute lymphoblastic leukemia has unusual transformationandnbsp; andnbsp; 3.8.4 Case study 4: To develop software that can run faster than the current flow cytometer softwareandnbsp; andnbsp; 3.8.5 Case study 5: To validate the mechanism of a candidate biologic drugandnbsp;3.9 Market Dynamicsandnbsp; andnbsp; 3.9.1 Driversandnbsp; andnbsp; andnbsp; andnbsp;3.9.1.1 andnbsp;Technological advancementsandnbsp; andnbsp; andnbsp; andnbsp;3.9.1.2 Clinical and research fieldsandnbsp; andnbsp; andnbsp; andnbsp;3.9.1.3 Increase in scope of Applications areasandnbsp; andnbsp; andnbsp; andnbsp;3.9.1.4 Investment in Randamp;Dandnbsp; andnbsp; andnbsp; andnbsp;3.9.1.5 Increase in number of patientsandnbsp; andnbsp; 3.9.2 RESTRAINTSandnbsp; andnbsp; andnbsp; andnbsp;3.9.2.1 Instrument costsandnbsp; andnbsp; andnbsp; andnbsp;3.9.2.2 Need of awarenessandnbsp; andnbsp; andnbsp; andnbsp;3.9.2.3 Need of trained personnelandnbsp; andnbsp; 3.9.3 OPPORTUNITIESandnbsp;andnbsp; andnbsp; andnbsp; andnbsp;3.9.3.1 In clinical approachandnbsp; andnbsp; andnbsp; andnbsp;3.9.3.2 Research approachCHAPTER 4 FLOW CYTOMETRY MARKET BY PRODUCTandnbsp;4.1 Global flow cytometry market, by product type, 2012-2020, $millionandnbsp; andnbsp; 4.1.1 Global flow cytometry Product market, by geography, 2012-2020, $millionandnbsp;4.2 Instrumentsandnbsp; andnbsp; 4.2.1 Global flow cytometry Product market ,by instruments, 2012-2020,$millionandnbsp; andnbsp; 4.2.2 Global flow cytometry-instruments market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.2.3 Key Market Driversandnbsp; andnbsp; andnbsp; andnbsp;4.2.3.1 Popularity of bench top flow cytometersandnbsp; andnbsp; andnbsp; andnbsp;4.2.3.2 Technological trendsandnbsp; andnbsp; 4.2.4 Platformsandnbsp; andnbsp; andnbsp; andnbsp;4.2.4.1 Types of platformsandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.4.1.1 Single-Platform Approachandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp;4.2.4.1.1.1 TYPES OF SINGLE PLATFORMandnbsp; andnbsp; andnbsp; andnbsp;4.2.4.2 Global flow cytometry Product market, by platform, 2012-2020,$millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.4.3 Global flow cytometry platform market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.4.4 Sortersandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.4.4.1 Types of Sortersandnbsp; andnbsp; andnbsp; andnbsp;4.2.4.5 Analysersandnbsp; andnbsp; 4.2.5 Replaceable Componentsandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.1 Drivers of Replaceable Components Marketandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.2 Global flow cytometry replaceable components market, by types, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.3 Global flow cytometry replaceable components market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.4 Filtersandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.5.4.1 Types of filtersandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.5.4.2 Global flow cytometry filters market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.5 Lasersandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.5.5.1 Global flow cytometry lasers market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.6 Detectorsandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.5.6.1 Global flow cytometry detectors market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;4.2.5.7 Othersandnbsp; andnbsp; andnbsp; andnbsp; andnbsp; andnbsp; 4.2.5.7.1 Global flow cytometry other components market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.2.6 Accessoriesandnbsp; andnbsp; andnbsp; andnbsp;4.2.6.1 Global flow cytometry Accessories market, by geography, 2012-2020, $millionandnbsp;4.3 Reagents and Consumablesandnbsp; andnbsp; 4.3.1 Drivers of Reagents and consumables marketandnbsp; andnbsp; 4.3.2 Global flow cytometry reagents and consumables market, by type, 2012-2020, $millionandnbsp; andnbsp; 4.3.3 Global flow cytometry reagents and consumables market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.3.4 Antibodiesandnbsp; andnbsp; andnbsp; andnbsp;4.3.4.1 Global flow cytometry antibodies market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.3.5 Dyesandnbsp; andnbsp; andnbsp; andnbsp;4.3.5.1 Global flow cytometry dyes market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.3.6 Beadsandnbsp; andnbsp; andnbsp; andnbsp;4.3.6.1 Global flow cytometry beads market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.3.7 Othersandnbsp; andnbsp; andnbsp; andnbsp;4.3.7.1 Reagent kitsandnbsp; andnbsp; andnbsp; andnbsp;4.3.7.2 Beadsandnbsp; andnbsp; andnbsp; andnbsp;4.3.7.3 Solutionsandnbsp; andnbsp; andnbsp; andnbsp;4.3.7.4 Buffersandnbsp; andnbsp; andnbsp; andnbsp;4.3.7.5 Global flow cytometry other reagents and consumables market, by geography, 2012-2020, $millionandnbsp;4.4 Softwareandnbsp; andnbsp; 4.4.1 Global flow cytometry market, by software, 2012-2020, $millionandnbsp; andnbsp; 4.4.2 Global flow cytometry- software market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.4.3 With-System Softwareandnbsp; andnbsp; andnbsp; andnbsp;4.4.3.1 Global flow cytometry with system market, by geography, 2012-2020, $millionandnbsp; andnbsp; 4.4.4 Third Party Softwareandnbsp; andnbsp; andnbsp; andnbsp;4.4.4.1 Global flow cytometry- third party market, by geography, 2012-2020, $millionandnbsp;4.5 Servicesandnbsp; andnbsp; 4.5.1 Global flow cytometry services market, by geography, 2012-2020, $millionCHAPTER 5 FLOW CYTOMETRY MARKET BY TECHNOLOGYandnbsp;5.1 Global flow cytometry market, by technology, 2012-2020, $millionandnbsp;5.2 Global flow cytometry- technology market, by geography, 2012-2020, $millionandnbsp;5.3 Bead-Based Flow cytometryandnbsp; andnbsp; 5.3.1 Drivers of Bead Based Flow Cytometry Marketandnbsp; andnbsp; andnbsp; andnbsp;5.3.1.1 Application in the field of andnbsp;genomicsandnbsp; andnbsp; andnbsp; andnbsp;5.3.1.2 Application in the field of proteomicsandnbsp; andnbsp; andnbsp; andnbsp;5.3.1.3 High competitive edgeandnbsp; andnbsp; 5.3.2 Global flow cytometry bead based market, by geography, 2012-2020, $millionandnbsp;5.4 Cell Based Flow Cytometersandnbsp; andnbsp; 5.4.1 Global flow cytometry cell based market, by geography, 2012-2020, $millionCHAPTER 6 FLOW CYTOMETRY MARKET BY APPLICATIONandnbsp;6.1 Drivers of the Flow Cytometry Application Marketandnbsp; andnbsp; 6.1.1 Research fundsandnbsp; andnbsp; 6.1.2 Need for management in disease controlandnbsp; andnbsp; 6.1.3 Increase in flow cytometry end usersandnbsp;6.2 Restraints of the flow cytometry application marketandnbsp;6.3 Global flow cytometry market, by applications, 2012-2020, $millionandnbsp;6.4 Global flow cytometry-application market , by geography, 2012-2020, $millionandnbsp;6.5 Research Applicationsandnbsp; andnbsp; 6.5.1 Global flow cytometry market, by research applications, 2012-2020, $millionandnbsp; andnbsp; 6.5.2 Global flow cytometry-research application market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.5.3 Cell Cycle Analysis and Cell Proliferationandnbsp; andnbsp; andnbsp; andnbsp;6.5.3.1 Global flow cytometry Cell cycle analysis and Cell proliferation market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.5.4 Apoptosisandnbsp; andnbsp; andnbsp; andnbsp;6.5.4.1 Drivers of Apoptosis marketandnbsp; andnbsp; andnbsp; andnbsp;6.5.4.2 Global flow cytometry Apoptosis market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.5.5 Cell Sortingandnbsp; andnbsp; andnbsp; andnbsp;6.5.5.1 andnbsp;Global flow cytometry Cell sorting market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.5.6 Transfection and Cell Viabilityandnbsp; andnbsp; andnbsp; andnbsp;6.5.6.1 Global flow cytometry Transfection and Cell viability market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.5.7 Othersandnbsp; andnbsp; andnbsp; andnbsp;6.5.7.1 Global flow cytometry other research application market, by geography, 2012-2020, $millionandnbsp;6.6 Clinical Applicationsandnbsp; andnbsp; 6.6.1 Global flow cytometry market, by clinical applications, 2012-2020, $millionandnbsp; andnbsp; 6.6.2 Global flow cytometry clinical application market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.6.3 Organ Transplantationandnbsp; andnbsp; andnbsp; andnbsp;6.6.3.1 Drivers of Organ transplantation marketandnbsp; andnbsp; andnbsp; andnbsp;6.6.3.2 Global flow cytometry organ transplant market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.6.4 Hematology Hematological Malignanciesandnbsp; andnbsp; andnbsp; andnbsp;6.6.4.1 Global flow cytometry Hematology hematological malignancies market, by geography, 2012-2020, $millionandnbsp; andnbsp; andnbsp; andnbsp;6.6.4.2 Myelomaandnbsp; andnbsp; andnbsp; andnbsp;6.6.4.3 Lymphomasandnbsp; andnbsp; andnbsp; andnbsp;6.6.4.4 Leukemiaandnbsp; andnbsp; 6.6.5 Cancer and Solid Tumourandnbsp; andnbsp; andnbsp; andnbsp;6.6.5.1 Drivers of Cancer and solid tumor marketandnbsp; andnbsp; andnbsp; andnbsp;6.6.5.2 Restraints of Cancer and solid tumor marketandnbsp; andnbsp; andnbsp; andnbsp;6.6.5.3 Global flow cytometry Cancer and solid tumor market, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.6.6 Immunodeficiency Disease-HIV Infectionandnbsp; andnbsp; andnbsp; andnbsp;6.6.6.1 Key facts about HIVandnbsp; andnbsp; andnbsp; andnbsp;6.6.6.2 Drivers of HIV marketandnbsp; andnbsp; andnbsp; andnbsp;6.6.6.3 Restraints of HIV marketandnbsp; andnbsp; andnbsp; andnbsp;6.6.6.4 Global flow cytometry Immunodeficiency disease-HIV infectionmarket, by geography, 2012-2020, $millionandnbsp; andnbsp; 6.6.7 Othersandnbsp; andnbsp; andnbsp; andnbsp;6.6.7.1 Global flow cytometry other clinical application market, by geography, 2012-2020, $millionCHAPTER 7 FLOW CYTOMETRY MARKET BY END USERandnbsp;7.1 Global flow cytometry market, by end user, 2012-2020, $millionandnbsp;7.2 Global flow cytometry end user market, by geography, 2012-2020, $millionandnbsp;7.3 Commercial Organizationsandnbsp; andnbsp; 7.3.1 Global flow cytometry commercial market, by geography, 2012-2020, $millionandnbsp;7.4 Medical Schools and Clinical Testing Labsandnbsp; andnbsp; 7.4.1 Global flow cytometry medical schools and clinical testing labs market, by geography, 2012-2020, $millionandnbsp;7.5 Hospitalsandnbsp; andnbsp; 7.5.1 Global flow cytometry hospitals market, by geography, 2012-2020, $millionandnbsp;7.6 Academicsandnbsp; andnbsp; 7.6.1 Global flow cytometry Academics market, by geography, 2012-2020, $millionandnbsp;7.7 Othersandnbsp; andnbsp; 7.7.1 Global flow cytometry other end user market, by geography, 2012-2020, $millionCHAPTER 8 FLOW CYTOMETRY MARKET BY GEOGRAPHYandnbsp;8.1 North Americaandnbsp; andnbsp; 8.1.1 Drivers of the North American Marketandnbsp; andnbsp; 8.1.2 North American flow cytometry market, 2012-2020, $millionandnbsp;8.2 Europeandnbsp; andnbsp; 8.2.1 Drivers of the European marketandnbsp; andnbsp; 8.2.2 European flow cytometry market, 2012-2020, $millionandnbsp;8.3 Asia Pacific and RoWandnbsp; andnbsp; 8.3.1 Asia and RoW flow cytometry market, 2012-2020, $millionCHAPTER 9 COMPANY PROFILESandnbsp;9.1 Advanced Analytical Technologies, Inc (AATI)andnbsp; andnbsp; 9.1.1 Company Overviewandnbsp; andnbsp; 9.1.2 Company Snapshotandnbsp; andnbsp; 9.1.3 Strategies and Developmentandnbsp; andnbsp; 9.1.4 Swot Analysis of Advanced AnalyticalTechnologiesandnbsp;9.2 Merck Milliporeandnbsp; andnbsp; 9.2.1 Company Overviewandnbsp; andnbsp; 9.2.2 Company Snapshotandnbsp; andnbsp; 9.2.3 Business Performanceandnbsp; andnbsp; 9.2.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.2.4.1 Primary strategies: Agreementandnbsp; andnbsp; andnbsp; andnbsp;9.2.4.2 Other strategiesandnbsp; andnbsp; 9.2.5 SwotAnalysis of Merck Milliporeandnbsp;9.3 Life Technologies Corporationandnbsp; andnbsp; 9.3.1 Company Overviewandnbsp; andnbsp; 9.3.2 Company Snapshotandnbsp; andnbsp; 9.3.3 Business Performanceandnbsp; andnbsp; 9.3.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.3.4.1 Primary Strategies: Agreementandnbsp; andnbsp; andnbsp; andnbsp;9.3.4.2 Secondary Strategies: Launch and Acquisitionandnbsp; andnbsp; 9.3.5 SwotAnalysis of Life Technologies Corporation.andnbsp;9.4 Beckman Coulter, Inc.andnbsp; andnbsp; 9.4.1 Company overviewandnbsp; andnbsp; 9.4.2 Company Snapshotandnbsp; andnbsp; 9.4.3 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.4.3.1 Primary strategies: product Launchandnbsp; andnbsp; andnbsp; andnbsp;9.4.3.2 Secondary strategies: Agreement andamp; acquisitionandnbsp; andnbsp; 9.4.4 Swot Analysis OF Beckman Coulter, Inc.andnbsp;9.5 Becton, Dickinson andamp; Co.andnbsp; andnbsp; 9.5.1 Company Overviewandnbsp; andnbsp; 9.5.2 Snapshot of Becton, Dickinson andamp; CO.andnbsp; andnbsp; 9.5.3 Business Performanceandnbsp; andnbsp; 9.5.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.5.4.1 Primary strategies: Launchandnbsp; andnbsp; andnbsp; andnbsp;9.5.4.2 Other strategiesandnbsp; andnbsp; 9.5.5 SWOT analysis of Becton, Dickinson andamp; Coandnbsp;9.6 Luminex Corporationandnbsp; andnbsp; 9.6.1 Company Overviewandnbsp; andnbsp; 9.6.2 Snapshotandnbsp; andnbsp; 9.6.3 Business Performanceandnbsp; andnbsp; 9.6.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.6.4.1 Primary strategies: Agreementandnbsp; andnbsp; andnbsp; andnbsp;9.6.4.2 Other strategiesandnbsp; andnbsp; 9.6.5 Swot Analysis of LUMINEX CORPORATIONandnbsp;9.7 AmnisCorporationandnbsp; andnbsp; 9.7.1 Company Overviewandnbsp; andnbsp; 9.7.2 Snapshotandnbsp; andnbsp; 9.7.3 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.7.3.1 Primary strategies: Launchandnbsp; andnbsp; andnbsp; andnbsp;9.7.3.2 Other strategiesandnbsp; andnbsp; 9.7.4 SwotAnalysis of AmnisCorporationandnbsp;9.8 Partec GmbHandnbsp; andnbsp; 9.8.1 Company Overviewandnbsp; andnbsp; 9.8.2 Snapshotandnbsp; andnbsp; 9.8.3 Strategies and Developmentandnbsp; andnbsp; 9.8.4 SwotAnalysis of Partec GmbHandnbsp;9.9 eBIOSCIENCE, Inc.andnbsp; andnbsp; 9.9.1 Company Overviewandnbsp; andnbsp; 9.9.2 Snapshotandnbsp; andnbsp; 9.9.3 Business Performanceandnbsp; andnbsp; 9.9.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp;9.9.4.1 Primary strategies: launchandnbsp; andnbsp; andnbsp; andnbsp;9.9.4.2 Other strategiesandnbsp; andnbsp; 9.9.5 Swot Analysis of eBioscience, Inc.andnbsp;9.10 MORPHOSYS AGandnbsp; andnbsp; andnbsp;9.10.1 Company Overviewandnbsp; andnbsp; andnbsp;9.10.2 Snapshotandnbsp; andnbsp; andnbsp;9.10.3 Business performanceandnbsp; andnbsp; andnbsp;9.10.4 Strategies and Developmentandnbsp; andnbsp; andnbsp; andnbsp; andnbsp;9.10.4.1 Primary strategies: Agreement, Launch.andnbsp; andnbsp; andnbsp; andnbsp; andnbsp;9.10.4.2 Other strategiesandnbsp; andnbsp; andnbsp;9.10.5 Swot Analysis of Morphosys AGLIST OF TABLES:TABLE 1 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)TABLE 2 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT TYPE, 2012-2020, $MILLIONTABLE 3 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY GEOGRAPHY 2012-2020 ($MILLION)TABLE 4 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY, INSTRUMENTS, 2012-2020, $MILLIONTABLE 5 GLOBAL FLOW CYTOMETRY-INSTRUMENTS MARKET BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 6 TYPES OF PLATFORMTABLE 7 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY PLATFORMS, 2012-2020, MILLIONSTABLE 8 GLOBAL FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 9 TYPES OF SORTERS:TABLE 10 GLOBAL FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)TABLE 11 ANALYZERS BY KEY PLAYERSTABLE 12 GLOBAL FLOW CYTOMETRY ANALYSERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)TABLE 13 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY REPLACEABLE COMPONENTS MARKET, 2012-2020, $MILLIONTABLE 14 GLOBAL FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 15 TYPES OF FILTERSTABLE 16 GLOBAL FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 17 GLOBAL FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 18 TYPES OF DETECTORSTABLE 19 GLOBAL FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 20 GLOBAL FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 21 GLOBAL FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 22 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2012-2020, $MILLIONTABLE 23 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 24 GLOBAL FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 25 GLOBAL FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 26 GLOBAL FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 27 GLOBAL FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 28 GLOBAL FLOW CYTOMETRY MARKET , BY SOFTWARE, 2012-2020, $MILLIONTABLE 29 GLOBAL FLOW CYTOMETRY- SOFTWARE MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 30 GLOBAL FLOW CYTOMETRY WITH SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 31 GLOBAL FLOW CYTOMETRY- THIRD PARTY MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 32 GLOBAL FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 33 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2012-2020, $MILLIONTABLE 34 GLOBAL FLOW CYTOMETRY- TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 35 GLOBAL FLOW CYTOMETRY BEAD BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 36 GLOBAL FLOW CYTOMETRY CELL BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 37 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATIONS, 2012-2020, $MILLIONTABLE 38 GLOBAL FLOW CYTOMETRY-APPLICATION MARKET , BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 39 GLOBAL FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2012-2020, $MILLIONTABLE 40 GLOBAL FLOW CYTOMETRY-RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 41 GLOBAL FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 42 GLOBAL FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 43 GLOBAL FLOW CYTOMETRY CELL SORTING MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 44 GLOBAL FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 45 GLOBAL FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 46 GLOBAL FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2012-2020, $MILLIONTABLE 47 GLOBAL FLOW CYTOMETRY CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 48 GLOBAL FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 49 GLOBAL FLOW CYTOMETRY HEMATOLOGY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 50 GLOBAL FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 51 GLOBAL FLOW CYTOMETRY IMMUNODEFICIENCY DISEASE-HIV INFECTION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 52 GLOBAL FLOW CYTOMETRY OTHER CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 53 GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2012-2020, $MILLIONTABLE 54 GLOBAL FLOW CYTOMETRY END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 55 GLOBAL FLOW CYTOMETRY COMMERCIAL MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 56 GLOBAL FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 57 GLOBAL FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 58 GLOBAL FLOW CYTOMETRY ACADEMICS MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 59 GLOBAL FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLIONTABLE 60 NORTH AMERICAN FLOW CYTOMETRY MARKET, 2012-2020, $MILLIONTABLE 61 EUROPEAN FLOW CYTOMETRY MARKET,2012-2020, $MILLIONTABLE 62 ASIA AND ROW FLOW CYTOMETRY MARKET, 2012-2020, $MILLIONTABLE 63 SNAPSHOT OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)TABLE 64 SNAPSHOTOF MERCK MILLIPORE,TABLE 65 SNAPSHOT OF LIFE TECHNOLOGIES CORPORATIONTABLE 66 SNAPSHOT OF BECKMAN COULTER, INC.TABLE 67 SNAPSHOT OF BECTON DICKINSONTABLE 68andnbsp; SNAPSHOT OF LUMINEX CORPORATIONTABLE 69 SNAPSHOT OF AMNISCORPORATIONTABLE 70 SNAPSHOT OF PARTEC GMBHTABLE 71 SNAPSHOT OF EBIOSCIENCE, INC.TABLE 72 SNAPSHOT OFandnbsp; MORPHOSYS AGandnbsp;LIST OF FIGURES:FIG. 1 FLOW CYTOMETRY MARKET DEFINITIONFIG. 2 TOP FACTORS IMPACTING FLOW CYTOMETRY MARKET(2013-2020)FIG. 3 TOP THREE WINNING STRATEGIES OF FLOW CYTOMETRY MARKET (2010-2013)FIG. 4 TOP INVESTMENT MARKETS BY CLINICAL APPLICATIONFIG. 5 TOP INVESTMENT MARKETS BY RESEARCH APPLICATIONFIG. 6 TOP INVESTMENT MARKETS BY END-USERSFIG. 7 PORTERandrsquo;S FIVE FORCE ANALYSISFIG. 8 TYPES OF PLATFORMFIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2012)FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA, MYELOMA (2013)FIG. 11 ESTIMATED NEW CASES AS PER TYPES OF LEUKEMIA (2013)FIG. 12 ESTIMATED NEW CASES AND DEATHS IN U.S.andnbsp; (2012)FIG. 13 TOP TEN COUNTRIES IN CANCER POPULATION (PER 1, 00,000 PEOPLE) 2011FIG. 14 POPULATION LIVING WITH HIV/AIDS (TOP TEN COUNTRIES) 2012FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES U.S (2013)FIG. 16 SWOT ANALYSIS OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)FIG. 17 FINANCIAL REVENUES OF MERCK MILLIPORE SALES BY BUSINESS UNIT (2012)FIG. 18 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHIC AREAS (2012)FIG. 19 SWOT ANALYSIS OF MERCK MILLIPOREFIG. 20 FINANCIAL REVENUES BY END MARKETS (2012)FIG. 21 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)FIG. 22 SWOT ANALYSIS OF LIFE TECHNOLOGIES CORPORATIONFIG. 23 SWOT ANALYSIS OF BECKMAN COULTER, INCFIG. 24 FINANCIAL REVENUES OF BECTON, DICKINSON andamp; CO. BY GEOGRAPHIC AREAS (2012)FIG. 25 FINANCIAL REVENUES OF BECTON, DICKINSON andamp; CO. BY BUSINESS UNITS (2012)FIG. 26 SWOT ANALYSIS OF BECTON, DICKINSON andamp; COFIG. 27 REVENUE BY SALES TO CUSTOMERS (2012)FIG. 28 SWOT ANALYSIS OF LUMINEX CORPORATIONFIG. 29 SWOT ANALYSIS OF AMNIS CORPORATIONFIG. 30 SWOT ANALYSIS OF PARTEC GMBHFIG. 31 SWOT ANALYSIS OF EBIOSCIENCE, INCFIG. 32 FINANCIAL REVENUES OF MORPHOSYS AG BY BUSINESS UNITS (2012)FIG. 33 FINANCIAL REVENUES OFandnbsp; MORPHOSYS AG BY GEOGRAPHIC AREAS (2012)FIG. 34 SWOT ANALYSIS OF MORPHOSYS AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.